Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter to the Editor
  • Published:

Association between high expression of natural killer related-genes (NCAM/CD94) and early death during induction in children with acute myeloid leukemia

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1

References

  1. Creutzig U, Zimmermmann M, Reinhardt D, Dworzak M, Stary J, Lehrnbecher T . Early deaths and treatment-related mortality in children undergoing therapy for acute myeloid leukemia: analysis of the multicenter clinical trials AML-BFM 93 and AML-BFM 98. J Clin Oncol 2004; 22: 4384–4393.

    Article  PubMed  Google Scholar 

  2. Scott A, Head D, Kopecky K, Appelbaum F, Theil K, Grever M et al. HLA-DR−, CD33+, CD56+, CD16− myeloid/natural killer cell acute leukemia: a previously unrecognized form of acute leukemia potentially misdiagnosed as French–american–british acute myeloid leukemia-M3. Blood 1994; 84: 244–255.

    CAS  PubMed  Google Scholar 

  3. Raspadori D, Damiani D, Lenoci M, Rondelli D, Testoni N, Nardi G et al. CD56 antigenic expression in acute myeloid leukemia identifies patients with poor clinical prognosis. Leukemia 2001; 15: 1161–1164.

    Article  CAS  PubMed  Google Scholar 

  4. Stucki A, Rivier AS, Gikic M, Monai N, Schapira M, Pertini O . Endothelial cell activation by myeloblasts: molecular mechanisms of leukostasis and leukemic cell dissemination. Blood 2001; 97: 2121–2129.

    Article  CAS  PubMed  Google Scholar 

  5. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Granlnich HR et al. A variant form of hypergranular promyelocytic variant (M3). Br J Haematol 1980; 44: 169–170.

    Article  CAS  PubMed  Google Scholar 

  6. Pieters R, Loonen AH, Huismans DR, Broekema GJ, Dirven MWJ, Heyenbrok MW et al. In vitro drug sensitivity of cells from children with leukemia using the MTT assay with improved culture conditions. Blood 1990; 76: 2327–2336.

    CAS  PubMed  Google Scholar 

  7. Novotny JR, NĂ¼ckel H, DĂ¼hrsen U . Correlation between expression of CD56/NCAM and severe leukostasis in hyperleukocytic acute myelomonocytic leukaemia. Eur J Haematol 2006; 76: 299–308.

    Article  CAS  PubMed  Google Scholar 

  8. Haferlach T, Kohlmann A, Schnittger S, Dugas M, Hiddemann W, Kern W et al. AML M3 and AML M3 variant each have a distinct gene expression signature but also share patterns different from other genetically defined AML subtypes. Genes Chromosomes Cancer 2005; 43: 113–127.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This study was financially supported in part by a grant of ‘Regione Siciliana’ and in part by a grant Associazione Italiana Ricerca sul Cancro (AIRC) and Associazione Italiana contro le Leucemie (AIL). DB was supported by a grant from IBISCUS. We thank Mr G Auteri and Mr N Bonanno for their technical support.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to L LoNigro.

Additional information

Supplementary Information accompanies the paper on the Leukemia website (http://www.nature.com/leu)

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Cite this article

LoNigro, L., Mirabile, E., Munda, S. et al. Association between high expression of natural killer related-genes (NCAM/CD94) and early death during induction in children with acute myeloid leukemia. Leukemia 22, 1778–1781 (2008). https://doi.org/10.1038/leu.2008.46

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/leu.2008.46

Search

Quick links